Davis R M Inc. Purchases 2,512 Shares of Stryker Corporation $SYK

Davis R M Inc. lifted its position in shares of Stryker Corporation (NYSE:SYK) by 1.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 138,732 shares of the medical technology company’s stock after purchasing an additional 2,512 shares during the period. Davis R M Inc.’s holdings in Stryker were worth $51,285,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in SYK. Kovack Advisors Inc. lifted its position in shares of Stryker by 3.6% during the 2nd quarter. Kovack Advisors Inc. now owns 771 shares of the medical technology company’s stock worth $305,000 after buying an additional 27 shares in the last quarter. Armstrong Advisory Group Inc. increased its position in shares of Stryker by 12.3% during the third quarter. Armstrong Advisory Group Inc. now owns 247 shares of the medical technology company’s stock valued at $91,000 after acquiring an additional 27 shares during the last quarter. Venturi Wealth Management LLC lifted its holdings in Stryker by 1.4% during the third quarter. Venturi Wealth Management LLC now owns 1,904 shares of the medical technology company’s stock worth $704,000 after acquiring an additional 27 shares during the period. Patriot Financial Group Insurance Agency LLC boosted its position in Stryker by 3.9% in the third quarter. Patriot Financial Group Insurance Agency LLC now owns 745 shares of the medical technology company’s stock worth $275,000 after purchasing an additional 28 shares during the last quarter. Finally, Wolff Wiese Magana LLC grew its stake in Stryker by 2.3% in the 3rd quarter. Wolff Wiese Magana LLC now owns 1,271 shares of the medical technology company’s stock valued at $470,000 after purchasing an additional 28 shares during the period. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Stryker

In other Stryker news, Director Ronda E. Stryker sold 250,000 shares of the business’s stock in a transaction that occurred on Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total value of $90,730,000.00. Following the completion of the transaction, the director owned 2,457,331 shares of the company’s stock, valued at $891,814,566.52. The trade was a 9.23% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 5.20% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

SYK has been the topic of a number of research analyst reports. UBS Group boosted their price target on shares of Stryker from $386.00 to $400.00 and gave the stock a “neutral” rating in a report on Tuesday, February 24th. Citizens Jmp upgraded shares of Stryker from a “market perform” rating to an “outperform” rating and set a $440.00 target price on the stock in a research note on Friday, December 19th. Evercore set a $390.00 target price on shares of Stryker in a research report on Monday, January 5th. Piper Sandler reaffirmed an “overweight” rating on shares of Stryker in a report on Tuesday, January 27th. Finally, Royal Bank Of Canada reissued an “outperform” rating and set a $435.00 price objective on shares of Stryker in a report on Friday, November 14th. Thirteen analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $426.47.

Stryker Trading Up 0.3%

Stryker stock opened at $387.34 on Monday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.21 and a current ratio of 1.89. Stryker Corporation has a fifty-two week low of $329.16 and a fifty-two week high of $404.87. The stock has a market cap of $148.23 billion, a P/E ratio of 46.11, a PEG ratio of 2.26 and a beta of 0.85. The firm’s fifty day moving average price is $363.17 and its 200-day moving average price is $369.09.

Stryker (NYSE:SYK) last posted its earnings results on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, topping the consensus estimate of $4.40 by $0.07. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The business had revenue of $7.17 billion during the quarter, compared to analysts’ expectations of $7.12 billion. During the same period in the previous year, the business earned $4.01 earnings per share. The firm’s revenue was up 11.4% on a year-over-year basis. Equities research analysts forecast that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, April 30th. Investors of record on Tuesday, March 31st will be paid a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, March 31st. Stryker’s dividend payout ratio (DPR) is currently 41.90%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.